Ortho Clinical Diagnostics Holdings Plc (OCDX) Return on Equity ROE from the first quarter 2022 to first quarter 2021 and annually, average high and low, overall ranking from Apr 03 2022 to Apr 04 2021 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Ortho Clinical Diagnostics Holdings Plc  (NASDAQ: OCDX)

Ortho Clinical Diagnostics Holdings Plc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Ortho Clinical Diagnostics Holdings Plc in the first quarter 2022?
Ortho Clinical Diagnostics Holdings Plc recorded a cumulative net loss of $0 million during 12 months ending in the first quarter 2022, resulting in a negative return on equity (ROE) of -0.1%.

Within the In Vitro & In Vivo Diagnostic Substances industry 2 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2022 from 0 to 1357.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Apr 03 2022)
I. Quarter		 (Jan 02 2022)
IV. Quarter		 (Oct 03 2021)
III. Quarter		 (Jul 04 2021)
II. Quarter		 (Apr 04 2021)
I. Quarter
Y / Y Equity Change 17.71 % - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions 0 -54 -85 -129 -150
Return On Equity (TTM) -0.1 % -13.93 % -246.71 % - -
OCDX's Total Ranking # 1357 # 0 # 0 # 0 # 0
Equity (TTM) in Millions 443 411 397 376 377
Seq. Equity Change 7.99 % 3.43 % 5.67 % -0.27 % -
Seq. Net Income Change - - - - -

Back to OCDX Management Effectiveness >> OCDX's 5 Years Annual ROE >> Compare OCDX ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 3
Sector # 129
Overall # 1357

Return On Equity Statistics
High Average Low
13.26 %
6.63 %
0 %
(Apr 03 2022)   (Jan 02 2022)





OCDX Annual Return On Equity (Jan 02 2022)
2022



Total Equity in Millions 411 0 0 0 0
Y / Y Equity Change - - - - -
Net Income in Millions -54 0 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity -13.23 % - - - -

Back to OCDX Management Effectiveness >> OCDX's 5 Years Annual ROE >> Compare OCDX ROE to its Competitors




More Return On Equity Ratios
In Vitro & In Vivo Diagnostic Substances Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
OCDX's' Return on Equity at Yahoo Finance
OCDX's Roe Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for OCDX's Competitors
Subscribers only: Roe for Ortho Clinical Diagnostics Holdings Plc's Suppliers
Subscribers only: Return On Equity for OCDX's Customers




Companies with similar Return On Equity at Apr 03 2022, within Healthcare Sector ROE

Date modified: 2026-09-08T15:10:37+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.